Vera Pins Hopes On Per-Protocol Analysis To Revive Phase II IgAN Asset

As Firm Reprioritizes Resources

 
• By Ayisha Sharma
Yellow line going down and then up, led by finger
Vera Is Determined To Advance Atacicept Into The Pivotal Stage • Source: Shutterstock

More from Clinical Trials

More from R&D